Search

everythinglearnresearchcommunity

for

Search:↓

Demodex mites are common in adults and elderly, emerging in children, and require careful diagnosis and treatment.

Skin organoids from stem cells could better mimic real skin but face challenges.

Effective treatments for discoid lupus erythematosus are needed, as current options are unsatisfactory and off-label.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Taking too much vitamin E caused a young man's blood clotting problems, which improved after he stopped the vitamin E and got treatment.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The model and estimator can predict drug exposure in kidney transplant patients well.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Early diagnosis, stopping the suspected drug, and supportive care are crucial for treating Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Finasteride raises suicide-linked aggression and stops clozapine's positive effects in schizophrenia animals.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Carbamazepine may cause lung problems and lupus-like symptoms, which can improve after stopping the drug.